BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 18720919)

  • 1. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results.
    Cole LA; Khanlian SA; Muller CY
    J Reprod Med; 2008 Jul; 53(7):457-64. PubMed ID: 18720919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors.
    Harvey RA; Pursglove HD; Schmid P; Savage PM; Mitchell HD; Seckl MJ
    J Reprod Med; 2008 Aug; 53(8):643-8. PubMed ID: 18773632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
    Khanlian SA; Cole LA
    J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USA hCG reference service, 10-year report.
    Cole LA; Laidler LL; Muller CY
    Clin Biochem; 2010 Aug; 43(12):1013-22. PubMed ID: 20493830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and therapeutics of placental site trophoblastic tumor].
    Deng S; Yang XY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):418-21. PubMed ID: 12905666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conservative approach in persistent low-level elevation of serum beta-human chorionic gonadotropin following chemotherapy for gestational trophoblastic neoplasia.
    Boafo-Yirenki M; Everard J; Tidy J; Hancock BW
    J Reprod Med; 2009 May; 54(5):288-90. PubMed ID: 19517692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate management of women with persistent low hCG results.
    Cole LA; Khanlian SA
    J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trophoblastic tumor on the placenta. Diagnosis, prognostic factors, treatments].
    Veschambre P; François H; Grosieux P
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(4):384-8. PubMed ID: 8815137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
    Cole LA; Kohorn E; Smith HO
    Obstet Gynecol Clin North Am; 2005 Dec; 32(4):615-26. PubMed ID: 16310675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-five years' clinical experience with placental site trophoblastic tumors.
    Papadopoulos AJ; Foskett M; Seckl MJ; McNeish I; Paradinas FJ; Rees H; Newlands ES
    J Reprod Med; 2002 Jun; 47(6):460-4. PubMed ID: 12092014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment.
    Hoekstra AV; Keh P; Lurain JR
    J Reprod Med; 2004 Jun; 49(6):447-52. PubMed ID: 15283052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of beta-subunit human chorionic gonadotropin level in the serum and first morning urine of patients with gestational trophoblastic disease.
    Benjapibal M; Wataganara T; Senawong S; Boriboonhirunsarn D; Suphanit I
    J Med Assoc Thai; 2001 Jul; 84(7):1000-5. PubMed ID: 11759958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental-site trophoblastic tumor following metastatic gestational trophoblastic neoplasia.
    Schneider D; Halperin R; Segal M; Bukovsky I
    Gynecol Oncol; 1996 Nov; 63(2):267-9. PubMed ID: 8910639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What we know about low-level hCG: definition, classification and management.
    Kohorn EI
    J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.